Liposome-encapsulated irinotecan (liposomal irinotecan)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Liposome-encapsulated irinotecan (liposomal irinotecan), covering 2025-12-30 to 2025-12-30. Get the full timeline:
Most recent: Clinical Trial Update: NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer [Phase 3]